Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised

Benjamin Honton1, Pascal Motreff2, Jean-Sébastien Mallet3

  • 1Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France.

Insights

Intravascular lithotripsy (IVL) demonstrated non-inferiority to rotational atherectomy (RA) in preparing calcified coronary lesions for percutaneous coronary intervention (PCI). Both strategies showed comparable safety and long-term clinical outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Management of calcified coronary lesions presents significant challenges in percutaneous coronary interventions (PCI).
  • The comparative efficacy of available plaque modification devices, including intravascular lithotripsy (IVL) and rotational atherectomy (RA), is not well-established.

Purpose of the Study:

  • To compare intravascular lithotripsy (IVL) and rotational atherectomy (RA) based strategies for plaque preparation in patients with moderate-to-severe calcified coronary lesions undergoing PCI.
  • To assess the non-inferiority of IVL compared to RA in achieving adequate lesion preparation.

Main Methods:

  • A multicenter, prospective, randomized non-inferiority trial involving 169 patients with moderate-to-severe calcified coronary lesions.
  • Interventions were guided by optical frequency domain imaging, comparing IVL and RA for plaque modification.
  • The primary endpoint was minimal stent area (MSA) post-stent implantation; target lesion failure (TLF) was assessed at 12 months.

Main Results:

  • IVL was non-inferior to RA for the primary endpoint of minimal stent area (MSA) (6.0±2.3 mm² vs 5.9±2.2 mm²).
  • Major strut malapposition was significantly less frequent with IVL (57.8%) compared to RA (80.2%).
  • Periprocedural complications and 12-month target lesion failure (TLF) rates were comparable between the IVL and RA groups.

Conclusions:

  • The IVL strategy is non-inferior to RA for plaque preparation in moderate-to-severe calcified coronary lesions during PCI.
  • IVL offers a comparable safety profile and equivalent clinical outcomes to RA.
  • These findings support IVL as an effective alternative for managing complex calcified coronary lesions.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...